Form 4: Guardant Health Director Receives Significant Equity Awards

Guardant Health, Inc. Director Meghan V. Joyce was granted 6,833 stock options and 4,203 restricted stock units (RSUs) as part of her compensation, aligning her interests with shareholders.

Summary

• Meghan V. Joyce, a Director at Guardant Health, Inc. (GH), reported the acquisition of derivative securities.
• On June 18, 2025, Ms. Joyce was granted 6,833 stock options with an exercise price of $50.57 per share.
• These stock options are set to expire on June 18, 2035.
• Additionally, on the same date, Ms. Joyce received 4,203 Restricted Stock Units (RSUs).
• Both the stock options and the RSUs will vest in full on the one-year anniversary of the grant date, June 18, 2025, or the date of the next annual stockholders meeting, whichever occurs earlier.
• Following these transactions, Ms. Joyce directly beneficially owns 6,833 stock options and 4,203 Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates standard compensation practices that align director interests with shareholders, without any negative implications from the filing itself.

Positives

• The grant of stock options and restricted stock units to a director helps align their financial interests with those of the company's shareholders, encouraging long-term value creation.
• Equity compensation is a standard practice for attracting and retaining qualified board members.

Future Outlook

The document does not contain forward-looking statements or guidance regarding the company's financial performance or strategic direction, focusing solely on an insider's equity transactions.

Industry Context

The granting of equity awards such as stock options and restricted stock units to directors is a common and widely accepted practice across various industries, particularly in the biotechnology and healthcare sectors where Guardant Health operates. This compensation structure is designed to incentivize long-term commitment and align the director's financial success with the company's performance and shareholder value.

Corporate Governance

Related Party Transactions

• The acquisition of stock options and restricted stock units by Meghan V. Joyce, a Director of Guardant Health, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: The equity awards align the director's financial interests with shareholder value, potentially leading to more focused long-term decision-making.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The stock options and restricted stock units will vest in full on the one-year anniversary of the grant date (June 18, 2025) or the date of the next annual stockholders meeting, whichever is earlier.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Transaction, Stock Option, Restricted Stock Units, RSU, Equity Award, Director Compensation, Beneficial Ownership